Source: Nutrition Insight

IFF: IFF expands pet nutrition portfolio with enzyme-based gut health solutions

IFF is expanding its pet portfolio with biotechnology solutions. The company's expansion focuses on enzyme-driven palatability with sustainable and clean label ingredients for cost-effective production. IFF's functional health technologies aim to support a complete pet life cycle. IFF is adding a range of enzyme-driven solutions to its pet portfolio, including Microsource CA and Betafin Pet.

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Erik J. Fyrwald's photo - CEO of IFF

CEO

Erik J. Fyrwald

CEO Approval Rating

66/100

Read more